Radiopharmaceutical Solutions Global and China Top Players Market

Radiopharmaceutical Solutions - Global and China Top Players Market Share and Ranking 2025

Radiopharmaceutical Solutions Global and China Top Players Market

Radiopharmaceutical Solutions - Global and China Top Players Market Share and Ranking 2025


The research report on ‘Radiopharmaceutical Solutions Market’ provides a workplan for stakeholders for the estimated timeframe of 2024-2031. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!





The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies and analyses global Radiopharmaceutical Solutions status and future trends, helping the client to determine the Radiopharmaceutical Solutions market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Radiopharmaceutical Solutions. It provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. To assess the competitive environment within the market, including supplier revenue, market share, and company profiles.

Radiopharmaceutical Solutions Market Key Takeaways

(1) Global Radiopharmaceutical Solutions market size, history data 2020-2024 , and forecast data 2024 -2031, (US$ million) & (K Units)
(2) Global Radiopharmaceutical Solutions sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(3) China Radiopharmaceutical Solutions sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(4) Global Radiopharmaceutical Solutions key consuming regions, consumption quantity, consumption value, and demand structure
(5) Global Radiopharmaceutical Solutions key producing regions, capacity, production, and year-over-year growth
(6) Radiopharmaceutical Solutions industry chains, upstream, midstream, and downstream

Radiopharmaceutical Solutions Market: Key Players

The competitive landscape of the Radiopharmaceutical Solutions Market offers a comprehensive analysis of key players. It includes insights such as company overviews, financial performance, revenue generation, market potential, research and development investments, new market strategies, regional presence, strengths and weaknesses, product launches, product range, and application leadership. These data points specifically pertain to the companies' activities and focus within the Radiopharmaceutical Solutions Market. Some of the major players operating in the Radiopharmaceutical Solutions Market are:
  • IBA
  • GE Healthcare
  • Actinium Pharmaceuticals
  • Alseres Pharmaceuticals
  • Cardinal Health
  • Jubilant Pharma
  • Central Research Laboratories
  • Cyclomedica
  • Bracco
  • Eckert & Ziegler Radiopharma


Market IntelliX's study on the Radiopharmaceutical Solutions market offers information divided into important segments — type, applications, end-use, and region. This report provides comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Radiopharmaceutical Solutions Market by Type [Analysis by Value from 2020 to 2031]:
  • Oral Tracking
  • Vein Tracking


Radiopharmaceutical Solutions Market by Application [Analysis by Value from 2020 to 2031]:
  • Hospitals
  • Health Systems
  • Others


Radiopharmaceutical Solutions Market by Region [Analysis by Value from 2020 to 2031]:
  • North America (United States, Canada and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Spain etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
  • South America (Brazil, Argentina and Colombia etc.)
  • Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)


Radiopharmaceutical Solutions Market Report Includes:

Chapter 1: To describe Radiopharmaceutical Solutions product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Radiopharmaceutical Solutions market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024

Chapter 3: China Radiopharmaceutical Solutions market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024

Chapter 4: Global key producing regions of Radiopharmaceutical Solutions , percent & CAGR, 2020 - 2031

Chapter 5: Radiopharmaceutical Solutions industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, and gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Radiopharmaceutical Solutions Definition

1.2 Global Radiopharmaceutical Solutions Market Size and Forecast

1.3 China Radiopharmaceutical Solutions Market Size and Forecast

1.4 Share of China Radiopharmaceutical Solutions Market with Respect to the Global Market

1.5 Radiopharmaceutical Solutions Market Size: China VS Global Growth Rate, 2020-2031

1.6 Radiopharmaceutical Solutions Market Dynamics

1.6.1 Radiopharmaceutical Solutions Market Drivers

1.6.2 Radiopharmaceutical Solutions Market Restraints

1.6.3 Radiopharmaceutical Solutions Industry Trends

1.6.4 Radiopharmaceutical Solutions Industry Policy

2 Global Leading Players and Market Share

2.1 By Revenue of Radiopharmaceutical Solutions, Global Market Share by Company, 2020-2025

2.2 Global Radiopharmaceutical Solutions Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.3 Global Radiopharmaceutical Solutions Concentration Ratio

2.4 Global Radiopharmaceutical Solutions Mergers & Acquisitions, Expansion Plans

2.5 Global Radiopharmaceutical Solutions Major Companies Product Type

2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking

3.1 By Revenue of Radiopharmaceutical Solutions, China Market Share by Company, 2020-2025

3.2 China Radiopharmaceutical Solutions Radiopharmaceutical Solutions Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis

4.1 Radiopharmaceutical Solutions Industry Chain

4.2 Radiopharmaceutical Solutions Upstream Analysis

4.2.1 Radiopharmaceutical Solutions Core Raw Materials

4.2.2 Main Manufacturers of Radiopharmaceutical Solutions Core Raw Materials

4.3 Midstream Analysis

4.4 Downstream Analysis

4.5 Radiopharmaceutical Solutions Production Mode

4.6 Radiopharmaceutical Solutions Procurement Model

4.7 Radiopharmaceutical Solutions Industry Sales Model and Sales Channels

4.7.1 Radiopharmaceutical Solutions Sales Model

4.7.2 Radiopharmaceutical Solutions Typical Distributors

5 Sights by Type

5.1 Radiopharmaceutical Solutions Classification

5.1.1 Oral Tracking

5.1.2 Vein Tracking

5.2 by Type, Global Radiopharmaceutical Solutions Consumption Value & CAGR, 2020 VS 2024 VS 2031

5.3 by Type, Global Radiopharmaceutical Solutions Consumption Value, 2020-2031

6 Sights by Application

6.1 Radiopharmaceutical Solutions Segment by Application

6.1.1 Hospitals

6.1.2 Health Systems

6.1.3 Others

6.2 by Application, Global Radiopharmaceutical Solutions Consumption Value & CAGR, 2020 VS 2024 VS 2031

6.3 by Application, Global Radiopharmaceutical Solutions Consumption Value, 2020-2031

7 Sales Sights by Region

7.1 By Region, Global Radiopharmaceutical Solutions Consumption Value, 2020 VS 2024 VS 2031

7.2 By Region, Global Radiopharmaceutical Solutions Consumption Value, 2020-2031

7.3 North America

7.3.1 North America Radiopharmaceutical Solutions Market Size & Forecasts, 2020-2031

7.3.2 By Country, North America Radiopharmaceutical Solutions Market Size Market Share

7.4 Europe

7.4.1 Europe Radiopharmaceutical Solutions Market Size & Forecasts, 2020-2031

7.4.2 By Country, Europe Radiopharmaceutical Solutions Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Radiopharmaceutical Solutions Market Size & Forecasts, 2020-2031

7.5.2 By Country/Region, Asia Pacific Radiopharmaceutical Solutions Market Size Market Share

7.6 South America

7.6.1 South AmericaRadiopharmaceutical Solutions Market Size & Forecasts, 2020-2031

7.6.2 By Country, South America Radiopharmaceutical Solutions Market Size Market Share

7.7 Middle East & Africa

8 Sales Sights by Country Level

8.1 By Country, Global Radiopharmaceutical Solutions Market Size & CAGR, 2020 VS 2024 VS 2031

8.2 By Country, Global Radiopharmaceutical Solutions Consumption Value, 2020-2031

8.3 United States

8.3.1 United States Radiopharmaceutical Solutions Market Size, 2020-2031

8.3.2 by Type, United States Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.3.3 by Application, United States Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.4 Europe

8.4.1 Europe Radiopharmaceutical Solutions Market Size, 2020-2031

8.4.2 by Type, Europe Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.4.3 by Application, Europe Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.5 China

8.5.1 China Radiopharmaceutical Solutions Market Size, 2020-2031

8.5.2 by Type, China Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.5.3 by Application, China Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.6 Japan

8.6.1 Japan Radiopharmaceutical Solutions Market Size, 2020-2031

8.6.2 by Type, Japan Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.6.3 by Application, Japan Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.7 South Korea

8.7.1 South Korea Radiopharmaceutical Solutions Market Size, 2020-2031

8.7.2 by Type, South Korea Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.7.3 by Application, South Korea Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.8 Southeast Asia

8.8.1 Southeast Asia Radiopharmaceutical Solutions Market Size, 2020-2031

8.8.2 by Type, Southeast Asia Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.8.3 by Application, Southeast Asia Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.9 India

8.9.1 India Radiopharmaceutical Solutions Market Size, 2020-2031

8.9.2 by Type, India Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.9.3 by Application, India Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.10 Middle East & Africa

8.10.1 Middle East & Africa Radiopharmaceutical Solutions Market Size, 2020-2031

8.10.2 by Type, Middle East & Africa Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

8.10.3 by Application, Middle East & Africa Radiopharmaceutical Solutions Consumption Value Market Share, 2024 VS 2031

9 Company Profile

9.1 IBA

9.1.1 IBA Company Information, Head Office, Market Area, and Industry Position

9.1.2 IBA Company Profile and Main Business

9.1.3 IBA Radiopharmaceutical Solutions Models, Specifications, and Application

9.1.4 IBA Radiopharmaceutical Solutions Revenue and Gross Margin, 2020-2025

9.1.5 IBA Recent Developments

9.2 GE Healthcare

9.2.1 GE Healthcare Company Information, Head Office, Market Area, and Industry Position

9.2.2 GE Healthcare Company Profile and Main Business

9.2.3 GE Healthcare Radiopharmaceutical Solutions Models, Specifications, and Application

9.2.4 GE Healthcare Radiopharmaceutical Solutions Revenue and Gross Margin, 2020-2025

9.2.5 GE Healthcare Recent Developments

9.3 Actinium Pharmaceuticals

9.3.1 Actinium Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

9.3.2 Actinium Pharmaceuticals Company Profile and Main Business

9.3.3 Actinium Pharmaceuticals Radiopharmaceutical Solutions Models, Specifications, and Application

9.3.4 Actinium Pharmaceuticals Radiopharmaceutical Solutions Revenue and Gross Margin, 2020-2025

9.3.5 Actinium Pharmaceuticals Recent Developments

9.4 Alseres Pharmaceuticals

9.4.1 Alseres Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

9.4.2 Alseres Pharmaceuticals Company Profile and Main Business

9.4.3 Alseres Pharmaceuticals Radiopharmaceutical Solutions Models, Specifications, and Application

9.4.4 Alseres Pharmaceuticals Radiopharmaceutical Solutions Revenue and Gross Margin, 2020-2025

9.4.5 Alseres Pharmaceuticals Recent Developments

9.5 Cardinal Health

9.5.1 Cardinal Health Company Information, Head Office, Market Area, and Industry Position

9.5.2 Cardinal Health Company Profile and Main Business

9.5.3 Cardinal Health Radiopharmaceutical Solutions Models, Specifications, and Application

9.5.4 Cardinal Health Radiopharmaceutical Solutions Revenue and Gross Margin, 2020-2025

9.5.5 Cardinal Health Recent Developments

9.6 Jubilant Pharma

9.6.1 Jubilant Pharma Company Information, Head Office, Market Area, and Industry Position

9.6.2 Jubilant Pharma Company Profile and Main Business

9.6.3 Jubilant Pharma Radiopharmaceutical Solutions Models, Specifications, and Application

9.6.4 Jubilant Pharma Radiopharmaceutical Solutions Revenue and Gross Margin, 2020-2025

9.6.5 Jubilant Pharma Recent Developments

9.7 Central Research Laboratories

9.7.1 Central Research Laboratories Company Information, Head Office, Market Area, and Industry Position

9.7.2 Central Research Laboratories Company Profile and Main Business

9.7.3 Central Research Laboratories Radiopharmaceutical Solutions Models, Specifications, and Application

9.7.4 Central Research Laboratories Radiopharmaceutical Solutions Revenue and Gross Margin, 2020-2025

9.7.5 Central Research Laboratories Recent Developments

9.8 Cyclomedica

9.8.1 Cyclomedica Company Information, Head Office, Market Area, and Industry Position

9.8.2 Cyclomedica Company Profile and Main Business

9.8.3 Cyclomedica Radiopharmaceutical Solutions Models, Specifications, and Application

9.8.4 Cyclomedica Radiopharmaceutical Solutions Revenue and Gross Margin, 2020-2025

9.8.5 Cyclomedica Recent Developments

9.9 Bracco

9.9.1 Bracco Company Information, Head Office, Market Area, and Industry Position

9.9.2 Bracco Company Profile and Main Business

9.9.3 Bracco Radiopharmaceutical Solutions Models, Specifications, and Application

9.9.4 Bracco Radiopharmaceutical Solutions Revenue and Gross Margin, 2020-2025

9.9.5 Bracco Recent Developments

9.10 Eckert & Ziegler Radiopharma

9.10.1 Eckert & Ziegler Radiopharma Company Information, Head Office, Market Area, and Industry Position

9.10.2 Eckert & Ziegler Radiopharma Company Profile and Main Business

9.10.3 Eckert & Ziegler Radiopharma Radiopharmaceutical Solutions Models, Specifications, and Application

9.10.4 Eckert & Ziegler Radiopharma Radiopharmaceutical Solutions Revenue and Gross Margin, 2020-2025

9.10.5 Eckert & Ziegler Radiopharma Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Radiopharmaceutical Solutions Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Radiopharmaceutical Solutions Market trending toward high growth trajectories?
A dynamic process in the Radiopharmaceutical Solutions Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like IBA, GE Healthcare, Actinium Pharmaceuticals, Alseres Pharmaceuticals, Cardinal Health, Jubilant Pharma, Central Research Laboratories, Cyclomedica, Bracco, Eckert & Ziegler Radiopharma.
How competitive is the Radiopharmaceutical Solutions Market going to be?
The strategic moves of the Radiopharmaceutical Solutions Market players such as IBA, GE Healthcare, Actinium Pharmaceuticals, Alseres Pharmaceuticals, Cardinal Health, Jubilant Pharma, Central Research Laboratories, Cyclomedica, Bracco, Eckert & Ziegler Radiopharma, and others clearly highlight consumer-centric strategies that use technology to improve customer experience.
What are the major applications of the Radiopharmaceutical Solutions Market?
Depending upon the type of applications, the Radiopharmaceutical Solutions Market has been segmented into and other applications.
What is the expected rate of growth in the Radiopharmaceutical Solutions Market?
From 2025 to 2030, the Radiopharmaceutical Solutions Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
What are the underlying opportunities in the Radiopharmaceutical Solutions Market?
The influx of capital into the Radiopharmaceutical Solutions Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
How does the Radiopharmaceutical Solutions Market study reflects the current scenario?
The Radiopharmaceutical Solutions study focuses on shifting market dynamics, geopolitical and regulatory regulations, and key players' strategies to carefully analyze demand at risk across multiple industry categories.